Vogelstein R Jacob
SEC insider (Form 3/4/5 filer). CIK 0002154030. Director & 10% Owner at Iambic Therapeutics, Inc. (IAM). 4 reported Form 4/5 transactions since Sep 2024; latest on Oct 16, 2026. Located in SAN DIEGO, CA.
Companies Vogelstein R Jacob has filed insider reports for
- Iambic Therapeutics, Inc. (IAM): Director, 10% Owner
Vogelstein R Jacob
CIK: 0002154030
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)3 (75.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IAM
Iambic Therapeutics, Inc.
Director10% Owner
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Oct 16, 2026IAM
Iambic Therapeutics, Inc.
ConversionIndirect2M shares- - Oct 16, 2026IAM
Iambic Therapeutics, Inc.
ConversionIndirect1.5M shares- - Oct 16, 2026IAM
Iambic Therapeutics, Inc.
ConversionIndirect742.5K shares- - Oct 14, 2026IAM
Iambic Therapeutics, Inc.
AwardDirectStock Option (right to buy)
20.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 16, 2026 | IAM Iambic Therapeutics, Inc. | Conversion | 1,995,749 | - | $0 | Indirect |
| Oct 16, 2026 | IAM Iambic Therapeutics, Inc. | Conversion | 1,458,290 | - | $0 | Indirect |
| Oct 16, 2026 | IAM Iambic Therapeutics, Inc. | Conversion | 742,546 | - | $0 | Indirect |
| Oct 14, 2026 | IAM Iambic Therapeutics, Inc. | Award Stock Option (right to buy) | 20,300 | - | - | Direct |
1-4 of 4 transactions